Mabion is a fully integrated CDMO offering a wide array of services associated with the development and manufacturing of protein-based biotherapeutics, including monoclonal antibodies and vaccine antigens. Mabion offers an end-to-end solution, covering all stages of biologic drug development, from early clone selection and small-scale manufacturing through process scale-up, large-scale DS and DP manufacturing and quality control down to sterile fill-finish in accordance with ISO and GMP. We also provide packaging and serialization, bioanalytical and regulatory support services.